15 Jan Date January 15, 2020 Categories News A phase II study in patients with Non-Alcoholic Fatty Liver Diseases (NAFLD) has been initiated ScandiBio Therapeutics has initiated a Phase II study in patients with Non-Alcoholic Fatty Liver Diseases (NAFLD) using Combined M...